Disruptions to cancer screening services have been experienced in most settings as a
consequence of the COVID-19 pandemic. Ideally, programmes would resolve backlogs by …

Abstract The American Cancer Society (ACS) recommends that individuals with a cervix
initiate cervical cancer screening at age 25 years and undergo primary human …

Background Cervical screening programs use testing for human papillomavirus (HPV)
genotypes. Different HPV types differ greatly in prevalence and oncogenicity. We estimated …

Purpose Colposcopy-directed biopsy is a cornerstone method for diagnosing cervical
intraepithelial neoplasia. The aim of this study was to evaluate the accuracy of colposcopy …

Background Cervical cancer disproportionately affects women≥ 65 years, especially those
not screened regularly. Speculum use is a key barrier. Aim To assess if offering non …

The rapidly increasing incidence and mortality of cancer calls for a focused effort to increase
the effect of cancer‐prevention efforts. In the area of early detection, there are major …

Background High-risk human papillomavirus (HPV) test is replacing cytology as the primary
cervical cancer screening test due to superior sensitivity, but in most countries women≥ 65 …

Objective Cervical cancer is caused by persistent infection with high-risk human
papillomavirus (hrHPV). Cytology-based national screening programs have reduced the …

An increase in cervical cancer incidence in Sweden from 2014 to 2015 has been attributed
to an increase in false‐negative cytological findings before cancer diagnoses. Years later …

Background Incidence of cervical cancer has been reduced by organized screening while
for vaginal and vulvar cancers no systematic screening has been implemented. All these …